NIPER Ahmedabad Announces High-Level Research Vacancies for AML Precision Chemotherapy Project

NIPER Ahmedabad has officially opened applications for senior research positions focused on a groundbreaking project in cancer therapeutics. Funded by the Indian Council of Medical Research (ICMR), the study aims to advance “Hit to Lead Optimization” for novel chemical hybrids designed to treat Acute Myeloid Leukemia (AML).

This initiative underscores NIPER Ahmedabad’s mission to serve as a premier hub for pharmaceutical innovation, leveraging its strategic proximity to India’s leading medical centers and biotech industries.

The Project: Combatting Leukemia with Adamantane-Quinoxalone Hybrids

The research, titled “Hit to Lead Optimization of Adamantane-Quinoxalone Hybrids for the Precision Chemotherapy of Acute Myeloid Leukemia,” is led by Dr. Dinesh Kumar, Associate Professor in the Department of Medicinal Chemistry.

The project focuses on developing targeted, small-molecule inhibitors. By combining Adamantane (known for its lipophilic properties) with Quinoxalone scaffolds, researchers hope to create a potent “precision” treatment that selectively targets leukemia cells, reducing the side effects typically associated with traditional chemotherapy.

Job Details & Remuneration

NIPER is looking for two highly qualified scientists to join this extramural grant project.

Position: Project Research Scientist-III (Non-Medical)
Total Vacancies: 02
Consolidated Salary: ₹1,01,400 per month (₹78,000 base + HRA).
Tenure: Initially for 1 year; extendable up to a total of 4 years based on performance and fund availability.
Age Limit: 45 years (relaxations apply per ICMR norms).

Candidate Profile: Qualifications & Skills

The institute is seeking specialists with a deep background in Synthetic Organic and Medicinal Chemistry.

Minimum Education

PhD with 2 years of post-qualification experience OR
Post Graduate degree (including integrated PG) with 5 years of post-qualification experience.

Technical Expertise Desired

Complex Synthesis: Proven track record in multi-step synthesis and functionalization of heterocyclic small molecules.
Modern Catalysis: Experience in transition-metal catalysis and C-H bond functionalization.
Green Chemistry: Candidates with experience in sustainable chemical processes will receive preference.
Academic Excellence: First-class marks in M.Sc., M.S. (Pharm.), M.Pharm., or M.Tech (Pharm.).

Application Process

The selection process involves a strict timeline and document verification:

Online Submission: Candidates must fill out the online application form by February 5, 2026.
Shortlisting: Only qualified candidates will be notified via email regarding the interview schedule (Online/Offline).
Verification: Original documents and a copy of the submitted application must be presented at the time of the interview.